BlackThorn Therapeutics is a clinical-stage biopharmaceutical company that uses a novel and robust platform (INFORM™) to link behavioral deficits with brain physiology to discover and develop targeted treatments for neurobehavioral disorders. We envision a future where patients with neurobehavioral disorders are quickly recognized, accurately diagnosed and effectively treated.